Dechra Pharmaceuticals PLC — Director's Dealing 2022

Oct 7, 2022

National Storage Mechanism | Additional information

RNS Number : 2317C

Dechra Pharmaceuticals PLC

07 October 2022

Friday, 7 October 2022

Dechra Pharmaceuticals PLC

(the Company)

Notification of Transactions by Person Discharging Managerial Responsibilities/Person Closely Associated With Them

Dechra Pharmaceuticals PLC has been notified that on 7 October 2022 Fiona Shipsey, the spouse of John Shipsey, Non-Executive Director, purchased 600 ordinary shares in the Company.

Following this acquisition, John Shipsey's beneficial interest in the Company is 600 shares (0.001% of the current issued share capital).

The Notification of Dealing Form set out below is provided in accordance with the requirements of the UK Market Abuse Regulation.

Notification of Dealing Form

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Fiona Shipsey
2.	Reason for the notification
a)	Position/status	PCA  of John Shipsey, Non-Executive Director
b)	Initial notification/amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Purchase of Shares
c)	Price(s) and volumes(s)	Price(s) £25.29497	Volume(s) 600
d)	Aggregated information -    Aggregate volume -    Price -    Total	600 £25.29497 £15,176.98
e)	Date of the transaction	7 October 2022
f)	Place of the transaction	London Stock Exchange

For further information, please contact:
Melanie Hall, Company Secretary
Telephone: 01606 814730

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide.  For more information please visit: www.dechra.com.

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBKOBBPBDDQKK